Wealth Enhancement Advisory Services LLC Acquires 11,175 Shares of STERIS plc $STE

Wealth Enhancement Advisory Services LLC lifted its holdings in STERIS plc (NYSE:STE) by 106.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,668 shares of the medical equipment provider’s stock after buying an additional 11,175 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in STERIS were worth $5,234,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Jones Financial Companies Lllp grew its holdings in STERIS by 46.1% in the first quarter. Jones Financial Companies Lllp now owns 1,106 shares of the medical equipment provider’s stock worth $251,000 after purchasing an additional 349 shares during the period. Goldman Sachs Group Inc. lifted its holdings in shares of STERIS by 32.3% during the first quarter. Goldman Sachs Group Inc. now owns 242,732 shares of the medical equipment provider’s stock valued at $55,015,000 after purchasing an additional 59,264 shares during the last quarter. Empowered Funds LLC boosted its position in shares of STERIS by 16.1% in the 1st quarter. Empowered Funds LLC now owns 2,303 shares of the medical equipment provider’s stock worth $522,000 after purchasing an additional 319 shares in the last quarter. Woodline Partners LP grew its stake in shares of STERIS by 40.0% in the 1st quarter. Woodline Partners LP now owns 8,300 shares of the medical equipment provider’s stock worth $1,881,000 after buying an additional 2,372 shares during the last quarter. Finally, Jane Street Group LLC grew its stake in shares of STERIS by 38.9% in the 1st quarter. Jane Street Group LLC now owns 20,716 shares of the medical equipment provider’s stock worth $4,695,000 after buying an additional 5,803 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors.

STERIS Trading Down 0.6%

Shares of NYSE:STE opened at $259.44 on Monday. STERIS plc has a 1 year low of $204.90 and a 1 year high of $269.44. The stock’s fifty day moving average price is $258.84 and its 200-day moving average price is $247.68. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.37 and a quick ratio of 1.63. The company has a market cap of $25.46 billion, a P/E ratio of 37.28 and a beta of 1.03.

STERIS (NYSE:STE) last announced its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.38 by $0.09. STERIS had a net margin of 12.07% and a return on equity of 14.43%. The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter last year, the firm posted $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. Sell-side analysts expect that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Tuesday, November 18th were paid a dividend of $0.63 per share. The ex-dividend date was Tuesday, November 18th. This represents a $2.52 dividend on an annualized basis and a yield of 1.0%. STERIS’s payout ratio is currently 36.21%.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a research note on Friday, January 9th. Seven analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $273.50.

Insider Activity

In other news, VP Julia Madsen sold 5,008 shares of the firm’s stock in a transaction on Friday, November 21st. The stock was sold at an average price of $262.00, for a total value of $1,312,096.00. Following the transaction, the vice president directly owned 10,710 shares in the company, valued at $2,806,020. This trade represents a 31.86% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, VP Renato Tamaro sold 5,036 shares of STERIS stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $257.55, for a total value of $1,297,021.80. Following the completion of the sale, the vice president directly owned 5,695 shares of the company’s stock, valued at $1,466,747.25. The trade was a 46.93% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 25,044 shares of company stock valued at $6,586,218 in the last ninety days. 1.07% of the stock is currently owned by company insiders.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.